Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ishares Genomics Immunology and Healthcare ETF (IDNA)

Ishares Genomics Immunology and Healthcare ETF (IDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 147,031,500
  • Market Capitalization, $K 147,032
  • Shares Outstanding, K 3,850
  • 60-Month Beta 1.23
  • Price/Earnings ttm 21.94
  • Annual Dividend & Yield 0.32 (0.86%)
  • Most Recent Dividend 0.084 on 06/15/20
  • Management Fee 0.47%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.85 +2.61%
on 07/31/20
41.30 -8.44%
on 07/20/20
-1.37 (-3.50%)
since 07/14/20
3-Month
33.92 +11.47%
on 05/27/20
41.30 -8.44%
on 07/20/20
+3.32 (+9.63%)
since 05/14/20
52-Week
22.32 +69.41%
on 03/16/20
41.30 -8.44%
on 07/20/20
+11.38 (+43.06%)
since 08/14/19

Most Recent Stories

More News
Moderna ETFs to Shine on U.S. Contracts for Coronavirus Vaccine

Moderna has inked a $1.5-billion coronavirus vaccine supply agreement with the U.S. government.

MRNA : 69.15 (+1.95%)
IBB : 133.36 (-0.48%)
CNCR : 25.92 (-1.59%)
XBI : 110.20 (-0.93%)
BBH : 161.45 (-0.22%)
BTEC : 44.39 (-1.14%)
IDNA : 37.81 (-1.07%)
GERM : 30.31 (+0.33%)
Moderna Turns Red Hot: Biotech ETFs to Bet On

Moderna skyrocketed 245% since it announced its COVID-19 vaccine candidate mRNA-1273 on Feb 10. The solid run is likely to continue as most of the analysts are optimistic on the stock.

MRNA : 69.15 (+1.95%)
IBB : 133.36 (-0.48%)
CNCR : 25.92 (-1.59%)
XBI : 110.20 (-0.93%)
BBH : 161.45 (-0.22%)
BTEC : 44.39 (-1.14%)
IDNA : 37.81 (-1.07%)
GERM : 30.31 (+0.33%)
Invest in the Future With Megatrend ETFs

These ETFs invest in fast growing areas like robotics and AI, genomics and cybersecurity.

REGN : 612.57 (+0.28%)
GILD : 68.50 (+0.47%)
MRNA : 69.15 (+1.95%)
IRBO : 32.20 (-0.37%)
TECB : 30.91 (-0.19%)
IHAK : 32.92 (-0.24%)
IDNA : 37.81 (-1.07%)
Moderna a Step Closer to Coronavirus Vaccine: ETFs to Gain

Moderna informs that the final-stage trial's primary aim will be to prevent the spread of coronavirus.

JNJ : 148.24 (+0.16%)
AZN : 55.19 (-1.09%)
MRNA : 69.15 (+1.95%)
IBB : 133.36 (-0.48%)
CNCR : 25.92 (-1.59%)
XBI : 110.20 (-0.93%)
BBH : 161.45 (-0.22%)
IDNA : 37.81 (-1.07%)
Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

GSK : 40.55 (-1.55%)
PBE : 59.33 (-1.22%)
ARKG : 58.56 (-1.43%)
GNOM : 17.92 (-1.65%)
IDNA : 37.81 (-1.07%)
Is Moderna Winning the COVID-19 Vaccine Race? ETFs to Gain

Moderna has presented positive interim data from a phase I study evaluating its mRNA-based coronavirus vaccine candidate.

JNJ : 148.24 (+0.16%)
SNY : 50.33 (-2.02%)
AZN : 55.19 (-1.09%)
MRNA : 69.15 (+1.95%)
GSK : 40.55 (-1.55%)
NVAX : 146.51 (+9.93%)
IBB : 133.36 (-0.48%)
CNCR : 25.92 (-1.59%)
XBI : 110.20 (-0.93%)
BBH : 161.45 (-0.22%)
IDNA : 37.81 (-1.07%)
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

GILD : 68.50 (+0.47%)
IBB : 133.36 (-0.48%)
CNCR : 25.92 (-1.59%)
BBH : 161.45 (-0.22%)
FBT : 162.83 (-0.89%)
PTH : 133.38 (+0.05%)
IHF : 209.79 (+0.40%)
IHE : 163.08 (+0.10%)
XPH : 43.87 (+0.16%)
SBIO : 41.13 (-1.27%)
XHS : 78.56 (+0.20%)
PBE : 59.33 (-1.22%)
IDNA : 37.81 (-1.07%)
Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

IBB : 133.36 (-0.48%)
CNCR : 25.92 (-1.59%)
BBH : 161.45 (-0.22%)
ARKG : 58.56 (-1.43%)
AYTU : 1.2900 (unch)
FTSV : 95.51 (+0.05%)
VIR : 52.74 (-0.02%)
IDNA : 37.81 (-1.07%)
CODX : 16.29 (-22.43%)
CNTG : 12.02 (-2.28%)
11-Year Bull Market Nears an End? ETFs That Should Survive

An oil collapse sent Wall Street into a tailspin on Mar 9, indicating that the 11-year-long bull market might soon end. These ETFs may, however, survive the crash.

PSK : 43.49 (+0.16%)
CLIX : 86.78 (-1.02%)
IDNA : 37.81 (-1.07%)
Wall Street in Correction: 4 Sector ETFs Unscathed in February

These sector ETFs gained or lost the least in the coronavirus-induced rout in February.

TSLA : 1,650.71 (+1.83%)
GLD : 182.54 (-0.43%)
ENPH : 73.16 (-2.30%)
SEDG : 219.21 (-2.65%)
TAN : 51.56 (-1.62%)
SGDM : 34.56 (-0.58%)
CLIX : 86.78 (-1.02%)
KURE : 33.62 (-0.30%)
CNRG : 63.56 (-1.53%)
IDNA : 37.81 (-1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IDNA with:

Fund Summary

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

See More

Key Turning Points

2nd Resistance Point 38.33
1st Resistance Point 38.07
Last Price 37.81
1st Support Level 37.63
2nd Support Level 37.45

See More

52-Week High 41.30
Last Price 37.81
Fibonacci 61.8% 34.05
Fibonacci 50% 31.81
Fibonacci 38.2% 29.57
52-Week Low 22.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar